Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
| Actual shortage: | 45 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
3 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2019-01-30 | 2019-10-15 | 73890 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Resolved | 2019-02-06 | 2019-10-15 | 74902 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Resolved | 2023-01-19 | 2023-03-02 | 181736 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2023-05-01 | 2023-05-09 | 191332 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2023-09-05 | 2024-04-09 | 203663 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2023-10-16 | 2024-05-22 | 207085 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2017-03-14 | 2017-07-05 | 2530 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2017-07-11 | 2017-08-02 | 15469 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2020-10-22 | 2020-11-28 | 126961 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-02-08 | 2022-02-25 | 154511 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-04-06 | 2022-09-28 | 158050 |
| VASOPRESSIN INJECTION USP | 20UNIT | SOLUTION | Resolved | 2022-11-28 | 2023-01-19 | 176073 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2022-11-28 | 2023-01-19 | 175970 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-03-03 | 2023-04-22 | 186176 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-07-10 | 2023-08-01 | 198005 |
| VERAPAMIL HYDROCHLORIDE INJECTION USP | 2.5MG | LIQUID | Resolved | 2023-11-06 | 2024-01-03 | 209230 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2021-09-13 | 2021-10-04 | 145576 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-02-01 | 2022-03-25 | 154002 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2022-06-29 | 2022-07-07 | 163618 |
| VISTITAN | 0.03% | SOLUTION | Resolved | 2023-04-11 | 2023-04-22 | 189229 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |